Peer Review

Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.

Our journal operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.

The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.

Submitted manuscripts will generally be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.


Peer reviewers involved in reviewing articles of the Clinical Oncohematology journal should follow the guidelines listed below.

  1. Committee on Publication Ethics (COPE) guidelines (Ethical Guidelines for Peer Reviewers ).
  2. Recommendations of the World Association for Medical Editors (WAME).
  3. Singapore Statement on Research Integrity.
  4. IСMJE recommendations (Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals).

If a peer reviewer disagrees with the policy of the Journal and it may affect the quality of the review because of fail to comply with the policy, he/she should refuse to review articles.

If a reviewer makes serious errors such as plagiarism, the editor-in-chief will notify the institution where the reviewer is working and will act in accordance with COPE guidelines .